NVCR Stock Analysis: Buy, Sell, or Hold?
NVCR - NovoCure Limited Ordinary Shares
$17.20
1.42 (9.00%)
▲
5d:
+14.29%
30d:
+8.72%
90d:
+58.67%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jul 23, 2026
19d
Smart Money Accumulation
None View Scanner →
Strength: 7.0/10
Get Alerted When NVCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NVCR shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: NVCR shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: NVCR is currently trading at $17.20, which is considered slightly high relative to its 30-day fair value range of $15.14 to $17.70.
Technical Outlook: Technically, NVCR is in a strong downtrend. The price is approaching resistance at $17.31. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 9.0% recently.
Market Sentiment: NVCR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.00 (+51.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NVCR is in a strong downtrend. The price is approaching resistance at $17.31. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 9.0% recently.
Market Sentiment: NVCR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.00 (+51.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$15.14 -
$17.70
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.0%)
- BULLISH: Trading 51.2% below Wall St target ($26.00)
Trading Range Analysis
30-Day Trading Range
$15.14 -
$17.70
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$13.43
Resistance Level
$17.31
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.42
Wall Street Target
$26.00
(+51.2%)
Revenue Growth (YoY)
12.3%
Earnings Growth (YoY)
-6.0%
Profit Margin
-25.7%
Share & Embed Analysis
Last updated: July 02, 2026 10:49 PM ET
Data refreshes hourly during market hours. Next update: 11:49 PM
Data refreshes hourly during market hours. Next update: 11:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Mukund Paravasthu
SELL
43246 shares
2026-03-05
Christoph Brackmann
SELL
6412 shares
2026-03-04
Frank X Leonard
SELL
5607 shares
2026-03-04
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 65 BUY |
Advanced NVCR Option Strategies
Professional options setups generated by AI based on today's NVCR price and gamma walls.
